New Key Statistics Module, Z-Score and F-Score
SHSE:603087 Key Ratios
Market Cap ¥ M | 27,138.10 |
Enterprise Value ¥ M | 21,746.69 |
P/E(ttm) | 46.07 |
PE Ratio without NRI | 56.02 |
Forward PE Ratio | 23.67 |
Price/Book | 2.42 |
Price/Sales | 9.05 |
Price/Free Cash Flow | 198.02 |
Price/Owner Earnings | 246.66 |
Payout Ratio % | 0.25 |
Revenue (TTM) ¥ M | 2,947.00 |
EPS (TTM) ¥ | 0.98 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 786.80 |
EV-to-EBIT | 57.19 |
EV-to-EBITDA | 57.19 |
PEG | -- |
Shares Outstanding M | 601.07 |
Net Margin (%) | 19.71 |
Operating Margin % | 10.86 |
Pre-tax Margin (%) | 18.96 |
Quick Ratio | 6.77 |
Current Ratio | 8.04 |
ROA % (ttm) | 4.97 |
ROE % (ttm) | 5.41 |
ROIC % (ttm) | 5.36 |
Dividend Yield % | 1.57 |
Altman Z-Score | 17.50 |
SHSE:603087 Number of Guru Trades
SHSE:603087 Volume of Guru Trades
Gurus Latest Trades with SHSE:603087
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603087 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gan & Lee Pharmaceuticals Co Ltd Insider Transactions
No Available Data